Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Class A Stock
- Shares outstanding
- 525,302,736
- Total 13F shares
- 324,262,108
- Share change
- +12,350,513
- Total reported value
- $1,326,293,585
- Put/Call ratio
- 80%
- Price per share
- $4.09
- Number of holders
- 332
- Value change
- +$25,282,966
- Number of buys
- 180
- Number of sells
- 137
Report period
Q4 2025
Institutions
332
Top holders
10
RXRX full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75629V104
Recent filing periods:
Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
13D/G
|
Company |
7.2%
from 13D/G
|
33,545,499
|
$163,702,036 | — | 30 Sep 2025 | |
| BAILLIE GIFFORD & CO |
13F
13D/G
|
Company |
4.6%
from 13D/G
|
23,978,695
|
$117,016,031 | — | 30 Sep 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
2%
|
7,725,096
|
$44,187,549 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
39,780,153
|
$194,127,147 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6%
|
31,739,765
|
$154,890,053 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
18,268,925
|
$89,152,354 | — | 30 Sep 2025 | |
| SOFTBANK GROUP CORP. |
13F
|
Company |
2.8%
|
14,667,491
|
$71,577,356 | — | 30 Sep 2025 | |
| Kinnevik AB (publ) |
13F
|
Company |
2.6%
|
13,434,171
|
$65,558,755 | — | 30 Sep 2025 | |
| Mubadala Investment Co PJSC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
12,985,927
|
$137,333,970 | — | 02 Mar 2023 | |
| MIC Capital Management UK LLP |
13F
|
Company |
1.8%
|
9,644,032
|
$47,062,881 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
9,623,557
|
$46,971,473 | — | 30 Sep 2025 | |
| Novo Holdings A/S |
13F
|
Company |
1.5%
|
7,929,835
|
$38,697,595 | — | 30 Sep 2025 | |
| NVIDIA CORP |
13F
|
Company |
1.5%
|
7,706,363
|
$37,607,051 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.4%
|
7,465,858
|
$36,433,387 | — | 30 Sep 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.4%
|
7,465,858
|
$36,358,728 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.4%
|
7,290,353
|
$35,576,930 | — | 30 Sep 2025 | |
| Data Collective IV GP, LLC |
13F
|
Company |
1.1%
|
5,941,120
|
$28,992,666 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
5,389,176
|
$26,299,178 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.8%
|
4,196,978
|
$20,481,253 | — | 30 Sep 2025 | |
| DCVC Opportunity Fund II GP, LLC |
13F
|
Company |
0.75%
|
3,951,141
|
$19,281,568 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.71%
|
3,753,778
|
$18,318,437 | — | 30 Sep 2025 | |
| Lingotto Investment Management LLP |
13F
|
Company |
0.7%
|
3,675,077
|
$17,934,376 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.66%
|
3,445,020
|
$16,811,698 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
3,337,296
|
$16,286,005 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0.61%
|
3,228,857
|
$15,756,823 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.47%
|
2,450,805
|
$11,959,928 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.34%
|
1,797,205
|
$8,770,360 | — | 30 Sep 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.34%
|
1,774,995
|
$8,661,976 | — | 30 Sep 2025 | |
| Bank Pictet & Cie (Europe) AG |
13F
|
Company |
0.31%
|
1,630,000
|
$7,954,400 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.3%
|
1,550,226
|
$7,565,102 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
1,369,657
|
$6,683,926 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
1,348,684
|
$6,581,578 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.24%
|
1,276,436
|
$6,229,008 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
1,261,620
|
$6,156,706 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
1,223,977
|
$5,973,009 | — | 30 Sep 2025 | |
| Comprehensive Financial Management LLC |
13F
|
Company |
0.18%
|
941,895
|
$4,596,448 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.16%
|
815,445
|
$3,979,372 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.15%
|
801,365
|
$3,910,663 | — | 30 Sep 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.14%
|
750,191
|
$3,660,932 | — | 30 Sep 2025 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.14%
|
726,024
|
$3,542,997 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.14%
|
721,554
|
$3,521,184 | — | 30 Sep 2025 | |
| Vestmark Advisory Solutions, Inc. |
13F
|
Company |
0.12%
|
621,059
|
$3,030,768 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.12%
|
620,600
|
$3,028,528 | — | 30 Sep 2025 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.11%
|
595,518
|
$2,906,128 | — | 30 Sep 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.11%
|
595,287
|
$2,905,001 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.11%
|
562,448
|
$2,744,746 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.11%
|
555,078
|
$2,708,781 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
520,785
|
$2,541,417 | — | 30 Sep 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
495,164
|
$2,416,400 | — | 30 Sep 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.08%
|
442,795
|
$2,160,851 | — | 30 Sep 2025 |
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q4 2025
As of 31 Dec 2025,
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by
332 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
324,262,108 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., ARK Investment Management LLC, STATE STREET CORP, BAILLIE GIFFORD & CO, SOFTBANK GROUP CORP., GEODE CAPITAL MANAGEMENT, LLC, MIC Capital Management UK LLP, Sumitomo Mitsui Trust Group, Inc., and Amova Asset Management Americas, Inc..
This page lists
332
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
321
Q4 2025 holders
332
Holder diff
11
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.